NasdaqGM - Nasdaq Real Time Price USD
Biodesix, Inc. (BDSX)
0.2200
-0.1391
(-38.74%)
At close: May 14 at 4:00:02 PM EDT
0.2304
+0.01
+(4.73%)
After hours: May 14 at 7:52:38 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 896,130 | 15 |
| Sales | 151,697 | 9 |
| Net Shares Purchased (Sold) | 744,433 | 24 |
| Total Insider Shares Held | 70.73M | -- |
| % Net Shares Purchased (Sold) | 1.10% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HUTTON SCOTT Chief Executive Officer | Sale at price 0.35 - 0.36 per share. | Direct | 1,344 | May 13, 2025 |
| O'KANE KIERAN Officer | Sale at price 0.35 - 0.36 per share. | Direct | 170 | May 13, 2025 |
| COWIE ROBIN HARPER Chief Financial Officer | Sale at price 0.35 - 0.36 per share. | Direct | 353 | May 13, 2025 |
| VAZQUEZ CHRISTOPHER Officer | Sale at price 0.35 - 0.36 per share. | Direct | 80 | May 13, 2025 |
| HUTTON SCOTT Chief Executive Officer | -- | Direct | -- | May 9, 2025 |
| O'KANE KIERAN Officer | -- | Direct | -- | May 9, 2025 |
| COWIE ROBIN HARPER Chief Financial Officer | -- | Direct | -- | May 9, 2025 |
| VAZQUEZ CHRISTOPHER Officer | -- | Direct | -- | May 9, 2025 |
| FRANCHI JEAN M Director | -- | Direct | -- | Apr 1, 2025 |
| PATIENCE JOHN Chairman of the Board | -- | Direct | -- | Mar 31, 2025 |
| WATTS CHARLES MCDONALD Director | -- | Direct | -- | Mar 31, 2025 |
| HUTTON SCOTT Chief Executive Officer | Sale at price 0.92 per share. | Direct | 77,319 | Feb 11, 2025 |
| O'KANE KIERAN Officer | Sale at price 0.92 per share. | Direct | 16,198 | Feb 11, 2025 |
| COWIE ROBIN HARPER Chief Financial Officer | Sale at price 0.92 per share. | Direct | 22,794 | Feb 11, 2025 |
| PESTANO GARY ANTHONY Officer | Sale at price 0.92 per share. | Direct | 15,479 | Feb 11, 2025 |
| VAZQUEZ CHRISTOPHER Officer | Sale at price 0.92 per share. | Direct | 3,355 | Feb 11, 2025 |
| HUTTON SCOTT Chief Executive Officer | -- | Direct | -- | Feb 10, 2025 |
| O'KANE KIERAN Officer | -- | Direct | -- | Feb 10, 2025 |
| COWIE ROBIN HARPER Chief Financial Officer | -- | Direct | -- | Feb 10, 2025 |
| PESTANO GARY ANTHONY Officer | -- | Direct | -- | Feb 10, 2025 |
| VAZQUEZ CHRISTOPHER Officer | -- | Direct | -- | Feb 10, 2025 |
| SCHULER JACK W Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.23 per share. | Indirect | 122,840 | Nov 21, 2024 |
| KENNEDY LAWRENCE T JR. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.16 per share. | Indirect | 40,562 | Nov 21, 2024 |
| SCHULER JACK W Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.17 per share. | Indirect | 234,000 | Nov 20, 2024 |
| HUTTON SCOTT Chief Executive Officer | Sale at price 1.39 - 1.40 per share. | Direct | 5,220 | Nov 12, 2024 |
| O'KANE KIERAN Officer | Sale at price 1.39 - 1.40 per share. | Direct | 645 | Nov 12, 2024 |
| COWIE ROBIN HARPER Chief Financial Officer | Sale at price 1.39 - 1.40 per share. | Direct | 1,355 | Nov 12, 2024 |
| PESTANO GARY ANTHONY Officer | Sale at price 1.39 - 1.40 per share. | Direct | 596 | Nov 12, 2024 |
| VAZQUEZ CHRISTOPHER Officer | Sale at price 1.39 - 1.40 per share. | Direct | 283 | Nov 12, 2024 |
| HUTTON SCOTT Chief Executive Officer | -- | Direct | -- | Nov 8, 2024 |
| O'KANE KIERAN Officer | -- | Direct | -- | Nov 8, 2024 |
| COWIE ROBIN HARPER Chief Financial Officer | -- | Direct | -- | Nov 8, 2024 |
| PESTANO GARY ANTHONY Officer | -- | Direct | -- | Nov 8, 2024 |
| VAZQUEZ CHRISTOPHER Officer | -- | Direct | -- | Nov 8, 2024 |
| KENNEDY LAWRENCE T JR. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.36 per share. | Indirect | 97,068 | Nov 6, 2024 |
| SCHULER JACK W Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.36 per share. | Indirect | 136,585 | Nov 5, 2024 |
| PATIENCE JOHN Chairman of the Board | Purchase at price 1.38 per share. | Indirect | 103,710 | Nov 5, 2024 |
| MASSARANY HANY Director | Purchase at price 1.37 per share. | Indirect | 30,866 | Nov 5, 2024 |
| STROBECK MATTHEW Director | Purchase at price 1.40 per share. | Indirect | 55,916 | Nov 5, 2024 |
| HUTTON SCOTT Chief Executive Officer | Sale at price 1.57 - 1.60 per share. | Direct | 5,966 | Aug 12, 2024 |
| O'KANE KIERAN Officer | Sale at price 1.57 - 1.60 per share. | Direct | 741 | Aug 12, 2024 |
| COWIE ROBIN HARPER Chief Financial Officer | Sale at price 1.57 - 1.60 per share. | Direct | 1,554 | Aug 12, 2024 |
| PESTANO GARY ANTHONY Officer | Sale at price 1.57 - 1.60 per share. | Direct | 687 | Aug 12, 2024 |
| VAZQUEZ CHRISTOPHER Officer | Sale at price 1.57 - 1.60 per share. | Direct | 333 | Aug 12, 2024 |
| HUTTON SCOTT Chief Executive Officer | -- | Direct | -- | Aug 8, 2024 |
| O'KANE KIERAN Officer | -- | Direct | -- | Aug 8, 2024 |
| COWIE ROBIN HARPER Chief Financial Officer | -- | Direct | -- | Aug 8, 2024 |
| PESTANO GARY ANTHONY Officer | -- | Direct | -- | Aug 8, 2024 |
| VAZQUEZ CHRISTOPHER Officer | -- | Direct | -- | Aug 8, 2024 |
| WATTS CHARLES MCDONALD Director | -- | Direct | -- | Jul 16, 2024 |
Related Tickers
MDXH MDxHealth SA
1.7800
-1.11%
MYGN Myriad Genetics, Inc.
3.8400
-6.57%
VCYT Veracyte, Inc.
28.49
-2.80%
NDRA ENDRA Life Sciences Inc.
3.1300
-0.95%
NEO NeoGenomics, Inc.
7.96
-4.78%
QGEN Qiagen N.V.
41.15
-2.28%
STRR Star Equity Holdings, Inc.
2.3500
-0.84%
PRPH ProPhase Labs, Inc.
0.3680
+8.78%
BIAF bioAffinity Technologies, Inc.
0.2250
+4.65%
XGN Exagen Inc.
5.82
+3.37%